Congress recently re-authorized user fees for medical devices. These user fees are paid by the manufacturers to the Food and Drug Administration to finance the regulatory process of licensing new medical devices.
However, user fees have been in effect since 2003, and the FDA has taken in the cash without improving output. Indeed, productivity has declined significantly since user fees took effect.
Read this month's Health Policy Prescription here.